Results 91 to 100 of about 55,045 (296)

Pretreatment anti-Müllerian hormone predicts for loss of ovarian function after chemotherapy for early breast cancer [PDF]

, 2013
Aim: Improving survival for women with early breast cancer (eBC) requires greater attention to the consequences of treatment, including risk to ovarian function. We have assessed whether biochemical markers of the ovarian reserve might improve prediction
Anderson, Richard A., Kelsey, Tom, Rosendahl, Mikkel, Kelsey, Thomas W., Anderson, Richard, Cameron, David A., Cameron, David   +6 more
core   +1 more source

Associations of Outdoor Air Pollution With Incidence of Cancers Other Than Lung Cancer in a Large US Prospective Cohort

International Journal of Cancer, EarlyView.
Associations between outdoor air pollution and cancers other than lung cancer remain unclear, particularly in the context of tobacco use. Here, the authors assessed possible links between ambient air pollutant exposure and incidence of 20 non‐lung cancers among adults followed over a 25‐year period in the United States.
W. Ryan Diver, Lauren R. Teras, Emily L. Deubler, Alpa V. Patel, Michelle C. Turner   +4 more
wiley   +1 more source

Hormone therapy for first-line management of menopausal symptoms: Practical recommendations

Women's Health, 2019
Hormone therapy use has undergone dramatic changes over the past 20 years. Widespread use of hormone therapy in the 1980s and 1990s came to an abrupt halt in the early 2000s after initial findings of the Women’s Health Initiative trial were published and
Santiago Palacios, John C Stevenson, Katrin Schaudig, Monika Lukasiewicz, Alessandra Graziottin   +4 more
doaj   +1 more source

Metabolic disorders in menopause

Menopause Review, 2015
Metabolic disorders occurring in menopause, including dyslipidemia, disorders of carbohydrate metabolism (impaired glucose tolerance – IGT, type 2 diabetes mellitus – T2DM) or components of metabolic syndrome, constitute risk factors for cardiovascular ...
Grzegorz Stachowiak, Tomasz Pertyński, Magdalena Pertyńska-Marczewska   +2 more
doaj   +1 more source

Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. [PDF]

, 2002
OBJECTIVE: To determine the effects of antiplatelet therapy among patients at high risk of occlusive vascular events. DESIGN: Collaborative meta-analyses (systematic overviews).
M. Catalano, Mccollum, Charles, Collaboration, Antithrombotic Trialists', Antithrombotic Trialists' Collaboration, Antithrombotic Trialists', Baigent, C, Collins, R, McCollum, CN, Antithrombotic Trialists' Collaboration, Sudlow, C, Peto, R   +9 more
core   +1 more source

Nitrogen‐Based Bisphosphonate Use and Risk of Cancer in Women Aged 50 Years and Older: A National Data Linkage Study

International Journal of Cancer, EarlyView.
Bisphosphonates are widely used to treat osteoporosis and to manage bone metastases in patients with breast cancer. Nitrogen‐based bisphosphonates may also broadly reduce cancer risk, but evidence remains inconsistent. This large population‐based data linkage study in women aged > 50 years found that, compared to no use of osteoporosis medicines ...
Karen M. Tuesley, Fiona Caristo, Katrina Spilsbury, Sallie‐Anne Pearson, Peter Donovan, Michael D. Coory, Christopher B. Steer, Susan J. Jordan   +7 more
wiley   +1 more source

Recent advances in the relationship between mental symptoms in postmenopausal women and estrogen fluctuations

Journal of Psychosomatic Obstetrics and Gynecology
Background Estrogen fluctuations during menopause are linked to increased psychiatric symptoms like depression and anxiety. Depression rates in menopausal women are 2–3 times higher than in premenopausal women, primarily due to rapid estrogen changes ...
Jiayi Zhu, Yuchang Huang, Jinghua Yuan, Lailing Du, Lin Huang, Xiaoping Li, Weicui Qi   +6 more
doaj   +1 more source

The Women's international study of long-duration oestrogen after menopause (WISDOM): a randomised controlled trial [PDF]

, 2007
Background: At the time of feasibility work and final design of the trial there was no randomised control trial evidence for the long-term risks and benefits of hormone replacement therapy.
Knott, C., Taylor, L., Tom W Meade, Welton, A., Meade, T., Vickers Madge R, Vickers, M., Meredith, S., Prince, M., Meade Tom W, Gordon, E., Huppert, F., Martin Jeannett, Meade, Tom W, Furness, P., Martin, J., Purdon, S., Martin, Jeannett, Collins, N., Ghali, M., Islam, Z., Vickers, Madge R, WISDOM study team, Arasaratnum, N., null null, Jeannett Martin, Walgrove, A., Wilkes, H., Ford, D., et al., Richards, M., Madge R Vickers   +31 more
core   +1 more source

Optimizing outcomes in intrauterine insemination: A narrative synthesis of two decades of clinical research (2000–2024)

International Journal of Gynecology &Obstetrics, EarlyView.
Abstract Intrauterine insemination (IUI) is a widely used first‐line fertility treatment, yet its success rates vary considerably. This review synthesizes evidence from peer‐reviewed studies published between 2000 and 2024, including randomized controlled trials, cohort and case–control studies, as well as systematic and narrative reviews identified ...
Kasuni Akalanka
wiley   +1 more source

WISDOM: history and early demise - was it inevitable?

, 2002
In 1989, the UK Medical Research Council (MRC) agreed that, if feasible, a randomized controlled trial to assess the long-term risks and benefits of hormone replacement therapy (HRT) was a priority.
Darbyshire, J, Meade, T, Vickers, M
core   +1 more source